Literature DB >> 1092407

Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.

H E Amos, W D Brigden, R A McKerron.   

Abstract

An antibody which sticks to the intercellular region of xenogenic epidermal tissue has been shown by indirect immunofluorescence to be present in the serum of patients with practolol-induced eye damage. These antibodies and those found in patients with pemphigus were compared for their ability to bind to isolated epidermal cells. Binding was achieved only with the pemphigus antibody, which suggests that it may have a different specificity from the antibody associated with practolol-induced eye damage.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092407      PMCID: PMC1672842          DOI: 10.1136/bmj.1.5958.598

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Cutaneous and ocular reactions to practolol.

Authors:  R H Felix; F A Ive; M G Dahl
Journal:  Br Med J       Date:  1974-11-09

2.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26
  2 in total
  21 in total

1.  Penicillamine-induced pemphigus.

Authors:  R A Marsden; H Hill; A G Mowat; M Walshe; R I Vanhegan; T J Ryan
Journal:  Proc R Soc Med       Date:  1977

2.  Editorial: side effects of practolol.

Authors: 
Journal:  Br Med J       Date:  1975-06-14

3.  Problems with practolol.

Authors:  H J Wall-Manning
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Editorial: Beta-blockers and the eye.

Authors: 
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

Review 5.  Side effects and contraindications of beta-receptor blocking agents.

Authors:  H Lydtin
Journal:  Klin Wochenschr       Date:  1977-05-01

6.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

7.  Psoriasis and psoriasiform eruptions associated with propranolol--the role of an immunological mechanism.

Authors:  S Halevy; E Livni
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

8.  Antinuclear antibodies in patients receiving non-practolol beta-blockers.

Authors:  J D Wilson; J Y Bullock; D C Sutherland; C Main; K P O'Brien
Journal:  Br Med J       Date:  1978-01-07

9.  Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).

Authors:  T C Orton; C Lowery; W E Lindup
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

10.  Practolol-induced SLE-like syndrome.

Authors:  M W Stewart; S W Clarke
Journal:  Proc R Soc Med       Date:  1976-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.